Patent Assignment
Reel/Frame 037804/0342
Assignment of Assignor's Interest
Recorded: 2016-02-23
Pages: 10
Assignors
MCKINNEY, ANTHONY ALEXANDER
Executed: 2013-10-03
BYMASTER, FRANK
Executed: 2013-10-03
WELTER, RICHARD
Executed: 2013-10-03
MARSHALL, RANDALL
Executed: 2015-11-04
Assignee
EUTHYMICS BIOSCIENCE, INC.
43 THORNDIKE STREET, SUITE S1-3, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Properties
(2)
Use of Amitifadine, (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane in Methods and Compositions with Enhanced Efficacy and Reduced Metabolic Side Effects and Toxicity for Treatment of Depression and Other Central Nervous System Disorders and Conditions Affected by Monoamine Neurotransmitters
Application:
13/964,024 →
Publication:
US 2016/0346249
Use of Amitifadine, (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane, in Methods and Compositions With Enhanced Efficacy and Reduced Metabolic Side Effects and Toxicity for Treatment of Depression and Other Central Nervous System Disorders and Conditions Affected by Monoamine Neurotransmitters
Application:
61/682,315 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.